CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics

COVID-19, the human coronavirus disease caused by SARS-CoV-2, was reported for the first time in Wuhan, China in late 2019. COVID-19 has no preventive vaccine or proven standard pharmacological treatment, and consequently, the outbreak swiftly became a pandemic affecting more than 215 countries arou...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Prashant, Malik, Yashpal Singh, Ganesh, Balasubramanian, Rahangdale, Somnath, Saurabh, Sharad, Natesan, Senthilkumar, Srivastava, Ashish, Sharun, Khan, Yatoo, Mohd. Iqbal, Tiwari, Ruchi, Singh, Raj Kumar, Dhama, Kuldeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673385/
https://www.ncbi.nlm.nih.gov/pubmed/33251158
http://dx.doi.org/10.3389/fcimb.2020.576875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673385/
https://www.ncbi.nlm.nih.gov/pubmed/33251158
http://dx.doi.org/10.3389/fcimb.2020.576875

Ejemplares similares